Skip to content
Screener

Pfizer PFE EV / EBITDA

EV / EBITDA at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
10.1×-0.2×
Eli Lilly logo
Eli LillyLLY
25.9×-24.4×
Johnson & Johnson logo
Johnson & JohnsonJNJ
19×+5.2×
Merck & Co. logo
Merck & Co.MRK
23.1×+11.7×
Amgen logo
AmgenAMGN
15.9×-1.3×
Incyte logo
IncyteINCY
10×+1.0×

Other financials

Income statement

See full
Revenue$15.0B+2.6%
Gross profit$10.9B+0.6%
Net income-$248.0M-109%
EPS (diluted)-$0.04-108%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+4.9%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$142.54B+6.6%
Enterprise value$205.21B+9.2%
P/E16×—
P/S2.2×+0.1×

Profitability

See full
Gross margin73.2%+1.1pp
Net margin15.7%—
FCF margin18%+8.8pp

Returns & leverage

See full
Return on equity10.6%—
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Calculated from Pfizer’s reported figures.

enterprise value/ebitda=12.9×

Based on the most recent quarter.

The source filing: Pfizer’s 10-Q, filed November 4, 2025. Open the filing →

Filed
Nov 4, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0000078003-25-000150

FAQ

What is Pfizer's EV / EBITDA?
Pfizer (PFE) reported EV / EBITDA of 12.9× in Q3 2025.
What is the long-term trend for Pfizer's EV / EBITDA?
Over 3 years (2020 to 2024), Pfizer's EV / EBITDA has grown at a -11.1% compound annual growth rate (CAGR), from 19.1× to 13.5×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about Pfizer's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude